Home
Bente Sandvei Skeie's picture

Bente Sandvei Skeie

Associate Professor
  • E-mailbente.s.skeie@uib.no
  • Visitor Address
    Jonas Lies vei 91
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). Growth dynamics of incidental meningiomas: A prospective long-term follow-up study. Neuro-Oncology Practice. 238-248.
  • Show author(s) (2023). First use of radiation for the treatment of arteriovenous malformation. Journal of Neurosurgery. 1348-1353.
  • Show author(s) (2022). Stereotactic Radiosurgery for Benign Cavernous Sinus Meningiomas: A Multicentre Study and Review of the Literature. Cancers.
  • Show author(s) (2022). Dynamic susceptibility contrast MRI may contribute in prediction of stereotactic radiosurgery outcome in brain metastases . Neuro-Oncology Advances (NOA). 10 pages.
  • Show author(s) (2022). Arterial input functions in dynamic susceptibility contrast MRI (DSC-MRI) in longitudinal evaluation of brain metastases. Acta Radiologica. 9 pages.
  • Show author(s) (2020). A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria. Neuro-Oncology Advances (NOA). 10 pages.
  • Show author(s) (2019). A prospective study of the natural history of incidental meningioma-Hold your horses! Neuro-Oncology Practice. 438-450.
  • Show author(s) (2018). Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. Journal of Neurosurgery. 71-83.
  • Show author(s) (2016). Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats. Journal of Neuro-Oncology.
  • Show author(s) (2016). Quality of life is maintained using Gamma Knife radiosurgery: A prospective study of a brain metastases patient cohort. Journal of Neurosurgery. 708-725.
  • Show author(s) (2016). Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models. BMC Cancer. 12 pages.
  • Show author(s) (2015). Drug repurposing: Sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc<sup>-</sup>, leading to glutathione depletion. Oncogene. 5951-5959.
  • Show author(s) (2014). Increased Survival Using Delayed Gamma Knife Radiosurgery for Recurrent High-Grade Glioma: A Feasibility Study . World Neurosurgery. e623-e632.
  • Show author(s) (2013). Gamma knife surgery of colorectal brain metastases: a high prescription dose of 25 Gy may improve growth control. World Neurosurgery. 525-536.
  • Show author(s) (2013). Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a Human GBM Xenograft Model. Biomedical Research. 9 pages.
  • Show author(s) (2012). Gamma knife surgery versus reoperation for recurrent glioblastoma multiforme. World Neurosurgery. 658-669.
  • Show author(s) (2011). Gamma Knife Surgery of Colorectal Brain Metastases: A High Prescription Dose of 25 Gy May Improve Growth Control. World Neurosurgery. 684-691.
  • Show author(s) (2011). Gamma Knife Surgery in Brain Melanomas: Absence of Extracranial Metastases and Tumor Volume Strongest Indicators of Prolonged Survival. World Neurosurgery. 684-691.
  • Show author(s) (2010). Gamma knife surgery of meningiomas involving the cavernous sinus: long-term follow-up of 100 patients. Neurosurgery. 661-669.
Lecture
  • Show author(s) (2024). Stereotactic radiosurgery and vestibular schwannomas.
  • Show author(s) (2024). Stereotactic radiosurgery and Trigeminal Neuralgia.
  • Show author(s) (2023). Meet the expert session: Management of vestibular schwannomas - Radiation therapy options.
  • Show author(s) (2022). SRS for drug resistant trigeminal neuralgia.
  • Show author(s) (2022). SRS for Glioblastoma.
  • Show author(s) (2022). Chair: Radiosurgery section, Asian and Australasian Society of Neurological Surgeons (AACNS) Meeting 2022.
  • Show author(s) (2011). Gamma Knife Treatment of cerebral metastases from colorectal cancer.
Academic lecture
  • Show author(s) (2024). A phase 2 trial evaluating anti-tumor efficacy of sulfasalazine in combination with gamma knife surgery for recurrent glioblastoma multiforme .
  • Show author(s) (2023). Phase I trial of sulfasalazine combined with stereotactic radiosurgery for recurrent glioblastoma: study protocol and preliminary results for NCT04205357 .
  • Show author(s) (2023). NCT04205357 – a phase I trial investigating Sulfasalazine as radiosensitizer in combination with Gamma Knife Radiosurgery for recurrent Glioblastoma and a Study protocol for a multicenter phase 2/3 trial. .
  • Show author(s) (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357.
  • Show author(s) (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357.
  • Show author(s) (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357.
  • Show author(s) (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357.
  • Show author(s) (2020). Robust DSC parameter estimations in patients with brain tumour metastases.
  • Show author(s) (2001). Gamma Knife Radiosurgery of meningiomas involving the cavernous sinus.
Doctoral dissertation
  • Show author(s) (2014). Gamma Knife Surgery for Intracranial Tumours – Clinical and Experimental studies.
Abstract
  • Show author(s) (2013). Sulfasalazine sensitizes glioblastoma cells to radiation treatment. Neuro-Oncology. 239-239.
  • Show author(s) (2013). COMBINED ANTI-ANGIOGENIC AND ANTI-INVASIVE TREATMENT OF ORTHOTOPICALLY ENGRAFTED HUMAN GBM XENOGRAFTS. Neuro-Oncology. 43-43.
Academic literature review
  • Show author(s) (2021). Lars Leksell - stereotaksiens far. Tidsskrift for Den norske legeforening. 1-2.
  • Show author(s) (2017). Drug repurposing in cancer. Pharmacological Research. 74-91.

More information in national current research information system (CRIStin)